| Acceptance rate | 46% |
|---|---|
| Time to first decision | 5 days* |
| Time to decision with review | 50 days* |
*approximate number of days
ACTA Pharmaceutica Sciencia
2009 , Vol 51 , Num 3
INFLUENCE OF ATORVASTATIN CALCIUM-CYCLODEXTRIN COMPLEXATION ON SOLUBILITY, STABILITY AND PHARMACODYNAMIC ACTIVITY